Reported 2026-03-25Lot GT20-032026-199.96% purity · 20.05 mg
Open COA
Lyophilized Peptides
Tirzepatide Research Reference — 20 mg
Catalog material presented by identity, format, availability and applicable lot documentation for qualified laboratory procurement.
CatalogGT-PW-20MG
SourceSee lot documentation
FormatLyophilized Peptides
StatusAvailable
$150.00 — or Original price was: $150.00.$127.50Current price is: $127.50. / month Current catalog price; lot availability controls fulfillment.
AvailabilityIn stock
7521 in stock
Subscribe monthly and save 15%$127.50 per delivery. The same price applies to the first order and recurring renewals.
- Guest checkout
- All major cards
- COA per lot
- 2-day shipping
- Cancel anytime
Tirzepatide Research Reference — 20 mg$150.00COA available
01Lot documentationCOA and analytical-record model
02Defined specificationMethod and result remain lot specific
03Tracked fulfillmentShipping method and lot allocation confirmed at order review
04Responsible useNon-clinical laboratory context
Lot documentation
Current Certificate of Analysis
8 approved certificates are attached to this product record.
Reported 2026-03-25Lot GT20-032026-199.96% purity · 20.05 mg
Open COA
Reported 2026-02-05Lot GT2b-02022026-J99.74% purity · 24.73 mg
Open COA
View all historical COAs (5)
Reported 2025-12-11Lot GT20-1201 2025-H99.934% purity · 20.59 mg
Open COA
Reported 2025-08-13Lot GT30-08112025-J99.9% purity · 30.09 mg
Open COA
Reported 2025-08-06Lot GT20-08042025-J99.82% purity
Open COA
Reported 2025-08-06Lot GT20-08042025-J99.82% purity · 21.43 mg
Open COA
Reported 2025-06-27Lot TIRZ20062025-N99.8% purity · 23.24 mg
Open COA
Technical information
Record at a glance
- Primary catalog
- Lyophilized Peptides
- Product type
- Simple product
- Availability
- Available
- Lot control
- Current lot documentation and approved product record control
- Catalog number
- GT-PW-20MG
Intended laboratory context
Illustrative applications
- Evaluation within the lawful context identified by the current product record
- Lot-specific documentation review before procurement or laboratory use
Documentation package
Documentation
- PDFCertificate of Analysis / lot recordSample
- PDFProduct data or handling recordSample
- PDFSupporting product media archiveSample
Intended use, handling, storage and limitations are controlled by the current product record, labeling and applicable lot documentation. No dosing or medical guidance is provided.
Need a current record?
Documentation before decision-making.
Reference GT-PW-20MG and the applicable lot when contacting technical support. Published files support evaluation but do not replace the approved lot COA or material specification.
View documentation model
